Cited by 20Per- and polyfluoroalkyl substances researchImmunotoxicology and immune responsesFluorine in Organic Chemistry

Evaluation of 147 perfluoroalkyl substances for immunotoxic and other (patho)physiological activities through phenotypic screening of human primary cells

Open access
Houck, Keith·2022·ALTEX

Abstract

A structurally diverse set of 147 per- and polyfluoroalkyl substances (PFAS) was screened in a panel of 12 human primary cell systems by measuring 148 biomarkers relevant to (patho)physiological pathways to inform hypotheses about potential mechanistic effects of data-poor PFAS in human model systems. This analysis focused on immunosuppressive activity, which was previously reported as an in vivo effect of perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS), by comparing PFAS responses to four pharmacological immunosuppressants. The PFOS response profile had little correlation with reference immunosuppressants, suggesting in vivo activity does not occur by similar mechanisms. The PFOA response profile did share features with the profile of dexamethasone, although some distinct features were lacking. Other PFAS, including 2,2,3,3-tetrafluoropropyl acrylate, demonstrated more similarity to the reference immunosuppressants but with additional activities not found in the reference immunosuppressive drugs. Correlation of PFAS profiles with a database of environmental chemical responses and pharmacological probes identified potential mechanisms of bioactivity for some PFAS, including responses similar to ubiquitin ligase inhibitors, deubiquitylating enzyme (DUB) inhibitors, and thioredoxin reductase inhibitors. Approximately 21% of the 147 PFAS with confirmed sample quality were bioactive at nominal testing concentrations in the 1-60 micromolar range in these human primary cell systems. These data provide new hypotheses for mechanisms of action for a subset of PFAS and may further aid in development of a PFAS categorization strategy useful in safety assessment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.14573/altex.2203041

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a study of potential immunosuppressive activity in a panel of 12 primary human cell systems and 148 relevant biomarkers, only 21% of the 147 PFAS analyzed showed bioactivity; PFOS activity profile showed little correlation with reference immunosuppressants; PFOA profile shares some features with dexamethasone but also unique characteristics.

    “In a study of potential immunosuppressive activity in a panel of 12 primary human cell systems and 148 relevant biomarkers, only 21% of the 147 PFAS analyzed showed bioactivity. The activity profile of PFOS showed little correlation with the reference immunosuppressants, suggesting that in vivo activity may occur via different mechanisms. The activity profile of PFOA shares some common features”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

15 of the 90 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

  1. CDC (2019). Fourth National Report on Human Exposure to Environmental Chemicals. Updated Tables, Volume One. doi: 10.15620/cdc75822 · DOI
  2. Gerçel-Taylor C, Ackermann MA and Taylor DD (2001). Evaluation of cell proliferation and cell death based assays in chemosensitivity testing. Anticancer Res 21, 2761– 2768. 11724352
  3. Young PW, Buckle DR, Cantello BC (1998). Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma. J Pharmacol Exp Ther 284, 751– 759. 9454824

Cited by

Sorted by citations

Authors
Houck, K.
Affiliations
Environmental Protection Agency (US)
Corresponding author
Houck, Keith
Venue
ALTEX
Publisher
ALTEX Edition
Published
2022
Volume
40
Issue
2
Pages
248–270-248–270
ISSN
  • 0946-7785 (ISSN-L)
  • 1868-596X
OpenAlex
W4296713605
Cited by
20
References
90
Citations by year
2026: 2 · 2025: 5 · 2024: 10 · 2023: 3
FWCI
1.59
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • ALTEX (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion, cc-by)
Funders
U.S. Environmental Protection Agency
Topics
  • Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Fluorine in Organic Chemistry
Keywords
per- and polyfluoroalkyl substances, PFAS, immunotoxicity, immunosuppression, primary human cells, phenotypic screening, PFOS, perfluorooctanoic acid, dexamethasone, ubiquitin ligase inhibitors, thioredoxin reductase inhibitors, mechanism of action, safety assessment, biomarkers
MeSH terms
Caprylates, Environmental Pollutants, Fluorocarbons, Humans, Alkanesulfonic Acids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review